Organization

University of Erlangen-Nuremberg

3 abstracts

Abstract
NOTOS: A pivotal study of navtemadlin, a first-in-class mouse double minute 2 inhibitor (MDM2i), in patients (pts) with TP53 wild-type (TP53WT) Merkel cell carcinoma (MCC) for whom anti PD-1/L1 therapy has failed.
Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Pittsburgh Medical Center, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Rogel Cancer Center, University of Michigan, Aix-Marseille University CHU Timone,
Abstract
A SNP IN NCF4 IS ASSOCIATED WITH RF NEGATIVE RA SUPPORTING A ROLE FOR THE NOX-COMPLEX IN AUTOIMMUNITY
Org: MEDICAL INFLAMMATION RESEARCH, Lund University, Department of Medicine, Icahn School of Medicine at Mount Sinai, Karolinska Institutet, Stockholm School of Economics Institute for Research, Stockholm, Sweden,